Aquestive Therapeutics, Inc.
AQST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001398733
In the last 90 days, Aquestive Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 185 institutions reported holding it in 13F filings for Q2 2026, worth $299.5M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Aquestive Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 180 | 1 | 185 | +6 |
| Shares | 71.9M | 1.73K | 72.0M | +111.7K (+0.2%) |
| Value | $298.6M | $7.16K | $299.5M | +$961.2K (+0.3%) |
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 416,248 | $1.73M | 0.00% |
| Man Group plc | 351,700 | $1.46M | 0.00% |
| HRT Financial LP | 344,811 | $1.43M | 0.00% |
| Lido Advisors, LLC | 215,316 | $895.7K | 0.00% |
| Gsa Capital Partners LLP | 116,260 | $484.0K | 0.03% |
| Virtu Financial LLC | 69,576 | $289.0K | 0.01% |
| Winton Group Ltd | 50,400 | $209.7K | 0.01% |
| Voleon Capital Management LP | 41,561 | $172.9K | 0.00% |
| Natixis | 25,963 | $108.0K | 0.00% |
| Wedbush Securities Inc | 14,500 | $60.0K | 0.00% |
| IMC-Chicago, LLC | 13,584 | $56.5K | 0.00% |
| Jain Global LLC | 12,468 | $51.9K | 0.00% |
| Xponance, Inc. | 10,324 | $42.9K | 0.00% |
| Pinnacle Financial Partners, Inc. | 10,000 | $41.6K | 0.00% |
| Avion Wealth | 1,000 | $16.0K | 0.00% |
| Caitong International Asset Management Co., Ltd | 3,321 | $13.8K | 0.00% |
| SRS Capital Advisors, Inc. | 2,125 | $8.84K | 0.00% |
| Silver Grove Financial Group, Inc. | 2,023 | $8.42K | 0.00% |
| Hurley Capital, LLC | 1,569 | $6.53K | 0.00% |
| Vima LLC | 600 | $2.50K | 0.00% |
| Global Retirement Partners, LLC | 7 | $29 | 0.00% |
| Clearstead Advisors, LLC | 5 | $21 | 0.00% |
| LifeSteps Financial, Inc. | 3 | $12 | 0.00% |
Sold out (17)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Diametric Capital, LP | 335,443 | $1.39M |
| Point72 Asset Management, L.P. | 283,734 | $1.18M |
| Prelude Capital Management, LLC | 51,054 | $211.9K |
| Trust Point Inc. | 31,048 | $128.8K |
| Y-Intercept (Hong Kong) Ltd | 26,992 | $112.0K |
| Millennium Management LLC | 25,851 | $107.3K |
| Drive Wealth Management, LLC | 20,537 | $85.2K |
| Two Sigma Securities, LLC | 18,770 | $77.9K |
| MBM Wealth Consultants, LLC | 16,950 | $70.3K |
| Independent Financial Group, LLC | 15,750 | $65.4K |
| Scientech Research LLC | 13,181 | $54.7K |
| Brinker Capital Investments, LLC | 12,967 | $53.8K |
| ADAR1 Capital Management, LLC | 10,000 | $41.5K |
| State of Wyoming | 753 | $3.13K |
| YANKCOM Partnership | 600 | $2.49K |
| True Wealth Design, LLC | 58 | $241 |
| MAI Capital Management | 5 | $21 |
Not filed for Q2 2026 yet (1)
Institutions that held Aquestive Therapeutics, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| CWM, LLC | 1,726 | $7.16K |